Open access

Hydroxysteroid Dehydrogenases – Localization, Function and Regulation in the Testis

Written By

Małgorzata Kotula-Balak, Anna Hejmej and Barbara Bilińska

Submitted: November 22nd, 2011 Published: November 14th, 2012

DOI: 10.5772/47740

Chapter metrics overview

3,137 Chapter Downloads

View Full Metrics

1. Introduction

Differentiation of the male phenotype including the outward development of secondary sex characteristics as well as the initiation and maintenance of spermatogenesis is stimulated by androgens (O'Shaughnessy et al., 2009; Verhoeven et al., 2010). There are two major androgens secreted by the testes: testosterone (T) and dihydrotestosterone (DHT). Weaker androgens: dehydroepiandrosterone (DHEA) and androstenedione are secreted in smaller amounts and converted metabolically to T and other androgens. Testosterone is the most abundant androgen. However, DHT is the most potent one.

As the result of intensive research over the last 20 years it has been confirmed that estrogens, produced by androgen aromatization, are also important in the regulation of male reproductive function (Carreau et al., 2003). In mice deficient for the estrogen receptor α gene (αERKO) infertility, increased steroid acute regulatory protein (StAR) and 17β-hydroxysteroid dehydrogenase (17β-HSD) mRNA levels together with elevated T level have been found (Akingbemi et al., 2003; Eddy et al., 1996).

Specific receptors for androgens and estrogens have been found in both somatic and germ cells of the testis (Bilinska et al., 2000; Bilinska & Schmalz-Fraczek, 1999; Sierens et al., 2005; Wang et al., 2009). It has been confirmed that these receptors act as transcription factors regulating steroidogenesis at the transcription level. Furthermore, steroidogenesis requires the coordinated expression of related proteins and steroidogenic enzymes in response to hormonal stimulation. In Leydig cells luteinising hormone (LH) induce steroidogenesis by elaborating accumulation of intracellular cyclic adenosine monophosphate (cAMP), activation of protein kinase A (PKA) and expression of StAR resulting in subsequent T biosynthesis and secretion. Intratesticular T is maintained at constantly high levels. In the rat, endogenous T concentrations are the highest at stage VIII of the spermatogenic cycle (Parvinen, 1982). In addition, this stage together with stage VII have been found to be particularly sensitive to androgen action, especially in four steps of germ cell development: spermatid adhesion and development, spermiation, progression through meiosis and spermatogonial differentiation (Verhoeven et al., 2010). Thus spermatogenesis is closely related and absolutely dependent on steroid hormone biosynthesis, action and control.

Advertisement

2. Steroidogenesis in the testis

In the male, Leydig cells which are present in the interstitium of the testis express all of the enzymes essential for the conversion of cholesterol to androgens and estrogens. The major pathways of steroid hormone synthesis are well established, and the sequence of the responsible steroidogenic enzymes has been elucidated (Payne & Hales, 2004). There are two major classes of steroidogenic enzymes: the cytochrome P450 heme-containing proteins and the hydroxysteroid dehydrogenases (HSDs). The first class contains: cytochrome P450 side chain cleavage (P450scc), cytochrome P450 17α-hydroxylase C17-C20 lyase (P450c17) and cytochrome P450 aromatase (P450arom), whereas the second includes both 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase (3β-HSD) and 17β-hydroxysteroid dehydrogenase/ketosteroid reductase (17β-HSD/KSR), (Payne, 2007).

The initial step of T biosynthesis is the conversion of the C27 cholesterol to the C21 pregnenolone (Figure 1). This reaction is catalyzed by the cytochrome P450scc, which is located in the inner mitochondrial membrane. Pregnenolone diffuses across the mitochondrial membrane and is further metabolized by enzymes associated with the smooth

Figure 1.

Steroid biosynthesis pathways in Leydig cell.

endoplasmic reticulum. P450c17 catalyzes the conversion of C21 pregnenolone or progesterone (P4) to the C19 dehydroepiandrosterone or androstenedione, respectively, while 3β-HSD catalyzes the conversion of Δ5-3β-hydroxysteroids (pregnenolone or dehydroxypregnenolone, and DHEA, respectively) to the Δ4-3-ketosteroids (P4, or 17α-hydroxyprogesterone, and androstenedione, respectively). Depending on the animal species, biosynthesis of sex hormones proceeds down either one or both of the Δ4 and Δ5 pathways. In rodents, the Δ4 pathway is primary whereas in primates, pigs and rabbits Δ5 pathway is dominant (Fluck et al., 2003; Mathieu et al., 2002). In the final step of sex hormones biosynthesis, conversion of androstenedione into T, 17β-HSD is involved. It was reported that the balance between these androgens depends on the type and activity of 17β-HSD present (Simard et al., 2005).

3β-HSDs are membrane-bound enzymes that are distributed in both mitochondrial and microsomal membranes (Payne & Hales, 2004; Pelletier et al., 2001). The relevance of dual localization of these HSDs is related to substrate accessibility (Simard et al., 2005). Coprecipitation studies have shown that, in the inner mitochondrial membrane, 3β-HSD comprises a functional steroidogenic complex with P450scc, which immediately provides substrates converted from cholesterol to the 3β-HSD (Cherradi et al., 1995).

During the past decade, multiple isoforms of 3β-HSDs have been isolated and characterized in human, mouse and rat tissues. Six, highly homologous in their amino acid sequence isoforms have been identified in the mouse, but only two of them: 3β-HSD type I (3β-HSD I), and 3β-HSD type VI (17β–HSD VI) are expressed in the testis. In human testis only 3β-HSD I has been found (Payne & Hales, 2004).

Similarly to 3β-HSDs, 17β-HSDs are membrane-bound enzymes, and their soluble forms have also been reported. To date, 14 different types of 17β–HSDs have been identified (Blanchard & Luu-The, 2007). Unlike 3β-HSDs there is very little homology among the different 17β-HSD enzymes. Only three types, 17β–HSD type 3 (17β–HSD 3), 17β–HSD type 5 and 17β–HSD type 12 (17β–HSD 12), have been detected to be exclusively expressed in the testis. 17β-HSD 3 converts androstenedione to T as well as it is an important partner of P450arom involved in conversion of C18 steroid, estrone to E2 (Andersson et al., 1995). Recently, it has been confirmed for mice, humans and primates that 17β-HSD 12 shares high homology and function with 17β-HSD 3 (Blanchard & Luu-The, 2007; Liu et al., 2007).

The hydroxysteroid dehydrogenases belong to the same phylogenetic protein family, namely the short-chain alcohol dehydrogenase reductase superfamily. These enzymes are involved in the reduction and oxidation of steroid hormones requiring NAD+/NADP+ as acceptors and their reduced forms as donors of reducing equivalents. Studies have shown that mouse 3β-HSD has different cofactor preference: 3β-HSD I requires NAD+ while 3β-HSD type IV and V requires NADP+ as cofactors. Interestingly, 17β-HSD 3 prefers NADPH as a cofactor, and its primary activity is reductive. Studies have shown that a mutation in HSD3B3gene leads to decreased NADPH binding to tyrosine that has been identified as a critical residue for binding. Substitution of tyrosine with different amino acids resulted in alterations in cofactor preference switching from NADPH to NADH (Andersson et al., 1995; McKeever et al., 2002). In addition, Schäfers et al. (2001) have reported different cofactor preference for 17β-HSD 3 on different days of postnatal development in rat.

Both 3β-HSD and 17β-HSD are well known Leydig cell-specific markers in different mammals, at different times of development and under different perturbation regimes (Bilinska, 1994; Hejmej et al., 2011b; Mendis–Handagama & Ariyaratne, 2001; Teerds et al., 2007). In previous studies, activity of HSDs in testis of various mammals was mostly detected using histochemical techniques (Badrinarayanan et al., 2006; Bilinska 1979, 1983, 1994; Hutson, 1989), (Figure 2). Nowadays the resolution of their localization increased with applying specific antibodies (Kotula-Balak et al., 2011; Pelletier et al., 1999; Pinto et al., 2010).

It has been reported that 3β-HSD type III (3β-HSD III) as well as 17β-HSD 3 and 17β-HSD type 10 are useful markers also for germ cells in rat, mouse, equine and black bear testis (Almeida et al., 2011; Ivell et al., 2003; O’Shaugnessy et al., 2000). Recently Scott et al. (2009) have indicated 17β-HSD 3 as a good marker for Sertoli cells in fetal mouse testis.

Figure 2.

A-B) Histochemical localization of 3β-HSD (A) and 17β-HSD (B) in cultured mouse Leydig cells. Note various intensity of the staining in the individual cells (arrows-strong staining, arrowheads-weak to moderate staining). Magnifications, x 320.

Advertisement

3. Age-dependent activity of HSDs

In testis of mammals two morphologically and functionally different Leydig cell populations have been identified. One develops prenatally (fetal Leydig cells, FLCs) and the second arises postnatally (adult Leydig cells, ALCs), (Mendis-Handagama & Aryiaratne, 2001; Pinto et al., 2010). These two generations have different gene expression profiles, which indicate that they originate from separate types of stem cell (Dong et al., 2007; O’Shaugnessy et al., 2002b). Differentiation of FLCs is initiated by human chorionic gonadotropin (hCG), whereas development of ALCs is critically dependent on LH (O’Shaughnessy et al., 1998). After birth the population of FLCs decreases in size, although some fetal-type cells persist even in the adult testis. In the rat, FLCs that are arranged in large compact clusters and contain numerous lipid droplets. In ALCs the nuclei are large and cytoplasmic content is sparse with a few lipid droplets. The cytoplasm of Leydig cells of both populations contains abundant smooth endoplasmic reticulum (SER) and tubulovascular mitochondria, which are important organelles in biosynthesis of steroid hormones.

The FLCs are fully competent steroidogenically. It has been demonstrated that in rat, FLCs start to express LH receptors (LHR) and 3β-HSD I from fetal day (fd) 15.5 (Payne & Hales, 2004). However in mouse, 3β-HSD I expression has been detected shortly before fd 11 (Baker et al., 1999). Recently with the use both histochemical and immunohistochemical methods the presence of 3α-hydroxysteroid dehydrogenase (3α-HSD) and 17β-HSD has also been confirmed in FLCs of rat (Haider, 2004).

From fd 15.5 FLCs start actively producing T and its synthesis increases gradually (Habert & Picon, 1984). Expression of hormone receptors and enzymes in FLCs arise continuously during existence of this population in the testis. Interestingly, Ivell et al. (2003) have demonstrated that 17β-HSD type 10 (17β-HSD 10) starts to be expressed at the time when FLCs begin to involute. However, the pick of oxidative activity of these enzyme has been determined on postnatal day (pd) 16 (Schäfers et al., 2001).

Fetal population of Leydig cells is the primary source of T, androstenedione and DHT in both fetal and early postnatal testis (Ariyaratne & Mendis-Handagama, 2000; Huhtaniemi & Pelliniemi, 1992). Multiple studies have shown that T-producing capacity of FLC is significantly greater than that of ALC and is calculated to be even 87 pg per cell (Aryaratne & Mendis-Handagama 2000; Huhtaniemi et al., 1982; Tapanainen et al., 1984).

During the neonatal-prepubertal period T is required for differentiation and morphogenesis of the male genital tract, activation of the hypothalamo-hypophyseal-testicular axis, completion of the testicular descent, masculinization of the brain, control of Sertoli cell number, initiation of spermatogenesis and formation of ALC precursors (Ariyaratne & Mendis-Handagama, 2000; Haider, 2004).

Steroidogenic capacity of FLCs is still high through the first postnatal week, although concentrations of circulating T are much lower due to decrease in number of these cells. Moreover, the inhibitory effects of Müllerian Inhibiting Substance (MIS) and transforming growth factor-bs (TGF-bs) on FLCs steroidogenic activity in postnatal testis have been described (Wu et al., 2007).

Testosterone production gradually increases to high levels with the development of ALCs (Benton, 1995; Chen et al., 2010; Hardy et al., 1989). The proliferation and differentiation of the adult population is regulated by an interplay of multiple regulatory factors, that can simulate, as well as inhibit, Leydig cells at each developmental stage. The development of ALCs is initiated around day 14 after birth and finishes around day 60. This process consists of multiple steps of proliferation and differentiation such as: proliferation of precursor cells; differentiation of precursor cells to Leydig cell progenitors, progenitors into newly formed adult Leydig cells, newly formed adult Leydig cells into immature adult Leydig cells; and finally, maturation of the immature adult Leydig cells to mature adult Leydig cells. In the rat, it has been reported that stem cells and mesenchymal precursor cells do not express steroidogenic enzymes however precursor cells acquire 3β–HSD III and other setroidogenic enzymes like cytochromes: P450scc and P450c17 prior to gain LHR (Hardy et al., 1989; Teerds et al., 2007; Zirkin, 2010). These cells have negligible amounts of 17β-HSD 3 while expression of steroid metabolizing enzymes 5α-reductase and 3α-HSD is high. Thus precursor cells produce androsterone as their main androgen product (O'Shaughnessy et al., 2000). Also expression of AR by early developmental stages of ALCs lineage is required for further transformations of these cells under androgen control (Ge & Hardy, 1997).

Differentiation of progenitors to newly formed adult Leydig cell is associated with the cell cytoplasm shape change from spindle shaped to polygonal. Newly formed Leydig cells move toward the central interstitium and locate near blood capillaries although they do not exclusively arrange in clusters. These cells express LHR and the levels of 3β–HSD VI, P450scc and P450c17 increase with the further steps of Leydig cell differentiation (Ariyaratne & Mendis-Handagama, 2000; Shan et al., 1993). It has been demonstrated that in mice Hsd3b3and Hsd3b6,remain fairly stable after birth but show a pubertal rise in expression around pd 20 (O'Shaughnessy et al., 2002)

5α-androstane-3α and 17β-diol is synthesized as the predominant androgen with the emergent increase in activity of 17β–HSD 3 and in a continuous presence of 5α-reductase and 3α-HSD (Hardy et al., 1990). It is worth noting, that in immature ALCs 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD 1) and 11β-hydroxysteroid dehydrogenase type 2 start to be expressed. In the rat testis, the presence of 11β-HSD 1 is in coincidence with the first appearance of elongated spermatids in the seminiferous tubules (Haider, 2004).

Adult Leydig cells are the dominant cell type of the Leydig cell lineage from pd 56 (Benton et al., 1995). Transformation of immature adult Leydig cells into mature adult Leydig cells is characterized by a significant increase in the average cell size and disappearance of cytoplasmic lipid droplets. The capacity to secrete T increases significantly in mature adult Leydig cells because of their enhanced responsiveness to circulatory LH due to the acquisition of higher numbers of LHR. During this time in the mouse testis, 3β-HSD VI becomes the predominant isoform of HSDs (Payne & Hales, 2004).

Additionally, the sharp decline in 5α-reductase activity overlaps. Shan et al. (1993) have reported that the mature Leydig cells by pd 90 produce 150 times more T than progenitors, and five times more than immature Leydig cells. Such high T levels are required for initiation, maintenance and regulation of the spermatogenesis. By day 90 the secretory capacity per ALC in rat has been estimated as 1.43 pg.

During puberty ALCs are particularly sensitive to androgens and expression of AR mRNA in this time is significant. Studies have shown that in the absence of AR, there is developmental failure of ALC maturation (O'Shaughnessy et al., 2010). However, there is well known phenomenon when ALCs destroyed by ethane dimethane sulphonate (EDS) administration can proliferate to regenerate the original population of Leydig cells (Teerds & Rijnities, 2007).

In aging human testis, both serum and intratesticular T concentrations progressively decline being in correlation to decreased LH level. In rat, these changes have been reported to be strain-dependent (Harman et al., 2001). In Brown Norway rats, the decrease in T level concomitantly with an increase in FSH level and unchanged LH level have been detected (Chen et al., 2002). Several studies have demonstrated that in men decrease in T level is associated with alterations in body composition, diminished energy, muscle strength and physical function, depressed mood and decreased cognitive function (Matsumoto, 2002). These age related changes result from the loss of steroidogenic capacity of the Leydig cells and/or reduction in their number (Chen et al., 2001, 2009). It has also been found that in aging Leydig cells adenyl cyclase is maintained that results in the defect of the cAMP-LH signaling cascade. In addition, protein and mRNA levels of StAR have been significantly reduced, suggesting deficits in the transport of cholesterol to the inner mitochondrial membrane of aged Leydig cells. Moreover, the activity, protein level, and mRNA level of P450scc, P450c17, 3β–HSD and 17β–HSD have been found markedly reduced in old Leydig cells (Ivell et al., 2003; Luo et al., 1996; Midzak et al., 2009; Zirkin & Chen, 2000). Interestingly, these authors have demonstrated that long-term suppression of steroidogenesis by administration of T prevents or delays the reduced steroidogenesis that accompanies Leydig cell aging due to suppressing the production of the reactive oxygen species that are a by-product of steroidogenesis itself.

Advertisement

4. Regulation of HSDs function

4.1. Pituitary hormones and other peptides

Primary control of 3β-HSD expression occurs through the activation by LH its receptor and the induction of the cAMP second messenger system (Simard et al., 2005). Recent findings from our own laboratory have revealed that bank vole Leydig cells treated with LH have increased steroidogenic capacity and T secretion (Gancarczyk et al., 2003). A profound hypogonadal effect and suppression of T production has been demonstrated in boars treated with deslorelin, an agonist of gonadotropin-releasing hormone (GnRH), (Kopera et al., 2008). In Leydig cells of treated boars very weak or lack of LHR and 3β-HSD expression has been detected. In contrast, Lin et al. (2008) who treated mouse Leydig cells with GnRH agonists (I and II) have demonstrated that 3β-HSD has been stimulated directly resulting in increase of T production. On the contrary, 17β-HSD was not induced in treated cells.

Formation of cAMP activates steroidogenesis by temporally distinct manners either, acutely (minutes) due to StAR action or chronically (hours) related on P450scc, P450c17, 3β-HSD and 17β-HSD activities. The delivery of cholesterol into the inner mitochondrial membrane is the rate-determining step in steroidogenesis. Also the differences in the way that cultured Leydig cells respond to cAMP have been reported. In mouse Leydig cells, cAMP has stimulated T production which then suppressed 3β-HSD at the mRNA level, whereas addition of cAMP to cultured rat Leydig cells increases 3β-HSD activity and expression at both the mRNA and protein level after 24–72 h (Keeney & Mason 1992; Payne & Sha 1991).

Interestingly, expression of 3β-HSD has been reported to be dependent upon steroidogenesis factor 1 (SF1). SF1 response element has been detected in the proximal promoter region of the human 3β-HSD type II gene. Recently Scott et al. (2009) have confirmed that the mouse 3β-HSD I gene promoter has three potential SF1 consensus binding sites. However, it is currently unknown whether SF1 regulates the expression of 17β–HSD.

A series of studies show that pituitary hormone-prolactin (PRL) and thyroid hormones regulate activity of HSDs. In Leydig cells of hypophysectomized rats treated with PRL, a significant increase in number of 3β-HSD immunopositive cells together with an increase in T and E2 concentrations was found (Dombrowicz et al., 1992; Manna et al., 2001). Also our own studies have revealed that in bank voles treated with PRL, the levels of androgens and estrogens have increased markedly within the testis (Gancarczyk et al., 2006). These results point the role of PRL in promoting multiplication, differentiation and regulation of steroidogenic function of Leydig cells. Similar functions have been confirmed for thyroid hormones. In physiological levels these hormones have profoundly increased the number of mesenchymal precursors of ALCs and supported their further differentiation (Maran, 2003; Mendis-Handagama et al., 1998; Teerds et al., 1998).

4.2. Steroids

In Leydig cells, the action of P4, has been reported to be mediated only by non-classical receptors while the classical nuclear progesterone receptor has not been found in these cells (Oettel & Mucopadhay 2004). The direct stimulatory or inhibitory effect of P4 on steroidogenesis in Leydig cells has been demonstrated, although its mode of action remains obscure (El-Hefnawy et al., 2000; Schwarzenbach et al., 2003). In rats, exposure in utero to subnormal levels of hydroxyprogesterone suppresses testicular steroidogenesis by decreasing the HSDs levels, which in turn suppresses the reproductive activity of the male (Pushpalatha et al., 2003). Studies have shown that in elderly men P4 levels increase within the testis and the spermatic vein, having a detrimental effect on Leydig cell steroidogenic function (El-Hefnawy & Huhtaniemi, 1998). It is interesting but still not resolved if and how P4 influences HSDs.

It has been reported that both endogenous and exogenous sex hormones are able to modify steroidogenesis at the level of 3β-HSD. In rats treated with an androgen antagonist, increased induction of hCG and 3β-HSD activity has been observed, whereas treatment with an androgen agonist decreased hCG induction and 3β-HSD activity, respectively (Ruiz de Galarreta et al., 1983). Similarly, T and DHT have inhibited 3β-HSD activity in adult rat and mouse Leydig cells (Simard et al., 2005). Recent findings by Kostic at al. (2011) have demonstrated that in andorgenized rats, T upregulated P4 synthesis. In these animals prolonged treatment with high T doses caused significant increase of 3β-HSD mRNA and protein levels whereas no effect has been observed on 17β-HSD expression. Freeman (1985) has demonstrated that E2 inhibited P4 biosynthesis in a dose-dependent manner in Leydig cells via inhibition of the activity of 3β-HSD. Also studies in vivoon rats and bank voles treated with E2 have shown disturbances in sex hormones balance within the testis. Low T and high E2 levels in treated animals have been reported to affect spermatogenesis (Gancarczyk et al., 2004; Rao & Chinoy, 1986).

4.3. Testicular paracrine factors

It has already been accepted that the function and activity of the testis is regulated by many locally produced factors and by cell-cell interactions. The effects of cytokines and growth factors on HSDs expression has been reported to be diverse (for review see Herrmann et al., 2002). Tumor necrosis factor (TNF) and interleukin 1 (IL-1) inhibited 3β-HSD activity in mouse and rat Leydig cells. However, IL-1 only inhibited cAMP stimulated enzyme synthesis, whereas TNF also reduced basal enzyme expression. In contrast, epidermal growth factor (EGF) increased activity and expression of 3β-HSD, which has also been demonstrated for transforming growth factor (TGF). Acidic fibroblast growth factor (aFGF) and basic fibroblast growth factor (bFGF) inhibited 3β-HSD. In pig Leydig cells, bFGH has been reported to increase 17β-HSD expression (Sordoillet et al., 1992). Our own studies in bank voles have revealed that insulin like growth factor I (IGF-I) stimulates whereas IL-1 and interleukin 1α (IL-1α) inhibit testis steroidogenic and spermatogenic function in sexually active males (Gancarczyk et al., 2006; Kmicikiewicz & Bilinska, 1997; Kmicikiewicz et al., 1999). Interesting results have been recently reported by Ivell et al. (2011) who demonstrated that 17β-HSD 10 mRNA expression in mice testis is regulated by locally produced relaxin (RLN) dependently of animal age.

4.4. Photopheriod

In seasonal breeders the function of the pituitary-testicular axis undergoes annual cyclic variations. Multiple studies including our own have shown that photoperiod is an important factor regulating steroidogenesis. Changes in LH and FSH secretion depending on the light length are responsible for seasonal variations in size, structure and function of the testis (Bartke & Steger, 1992). Under laboratory conditions, bank voles kept in long light regime show higher testis weight and increased steroidogenic activity than animals exposed to short one (Bilinska et al., 2000, 2001; Tähkä et al., 1982). In several seasonal breeders, the serum and testicular concentrations of steroid hormones have exhibited seasonal fluctuations and are always lower in regressed animals (Frungieri et al., 1999; Hance et al., 2009; Kotula-Balak et al., 2003).

In addition, the Leydig cell morphology as well as localization and expression of HSDs have been found to change seasonally in the sika deer, black bear and northern fur seal (Hayakawa et al., 2010; Ibluchi et al., 2010; Tsubota et al., 1997, 2001). In black bears during their mating season, 17β-HSD 3 has been detected both in Leydig cells and in Sertoli cells. Moreover, in these animals expression of 3β-HSD was the highest in June. In Syrian hamster, specific melatonin receptors (mel1a) have been reported in Leydig cells via which melatonin down-regulated the gene expression of both 3β-HSD, and 17β-HSD (Frungieri et al., 2005).

4.5. Endocrine disrupting chemicals

A large body of information concerning the effects of endocrine disrupting compounds (EDCs) on Leydig cells steroidogenesis during fetal development and in adult mammals has been accumulated in the past decades. EDCs can disturb morphology and normal endocrine functions of the Leydig cells or oppose the actions of androgen through their estrogenic or anti-androgenic properties (Hejmej et al., 2011a). A number of compounds act directly on Leydig cells to diminish T production by interfering with the expression of steroidogenic enzymes, at the protein and/or mRNA level (Skakkebaek, et al., 2001).

Our recent results have shown that administration of the estrogenic compound, 4-tert-octylphenol (OP), to adult bank voles has caused the significant decrease of 3β-HSD and increase of P450arom expression concominantly with the alteration of the androgen/estrogen balance within the tesis of sexually active animals (Hejmej et al,. 2011b). Similar results have been reported by Victor-Costa et al. (2010) on rats treated with atriazine. These authors concluded that inhibition of 3β-HSD function is one of the possible mechanism through which xenoestrogens disturb spermatogenesis. In vitrostudies on Leydig cells obtained from various mammals have revealed decrease in the activity and expression of 3β-HSD after OP, bisphenol A (BPA) and genistein administration (Hu et al., 2010; Kotula-Balak et al., 2011; Ye et al., 2011). Our study demonstrated that OP markedly disturbes morphology and steroidogenic function of the Leydig cells through direct effect on 3β-HSD expression and localization (Kotula-Balak et al., 2011). In detail, treatment with high doses of OP (10-4–10-6 M) resulted in a reduced staining intensity and the staining was usually located near the nucleus, whereas in the low OP doses (10-7 and 10-8 M) it was manly dispersed throughout the cytoplasm (Figure 3).

Figure 3.

A-C) Immunostaining for 3β-HSD. Positive staining of various intensity is confined to the cytoplasm of Leydig cells (arrows). Note, clearly reduced staining for 3β-HSD in Leydig cells treated with high OP dose (B). In many cells weak to moderate staining in the perinuclear region is visible (arrowheads). In Leydig cells treated with low OP dose (C) the intensity of immunostaining is similar to that of the control (A), (arrows). Only in a few cells staining in the perinuclear region is visible (arrowhead). Bars 20 µm.

It is worth noting that the effect of EDCs on HSDs function can be diverse depending on the choice of animal species, age, routes of administration and dose levels. Studies of Pogrmic-Majkic et al. (2010) have shown that in rat Leydig cells atriazine stimulated 17β-HSD, whereas other authors reported inhibition of these enzyme in rat and human microsomes treated with various xenoestrogens (Hu et al., 2010; Vaithinathan et al., 2008; Ye et al., 2011). Recently, it has also been found that antiandrogens such as tributylin, triclosan and flutamide modified HSDs expression in Leydig cells and microsomes of various mammals (Kim et al., 2008; Kumar et al., 2009; McVey & Cooke, 2003; Ohno et al., 2005; Ohsako et al., 2003).

Advertisement

5. HSDs in pathological conditions

5.1. Temperature and 3β-HSD activity

In recent years, disorders of human male reproductive development increased in incidence (Sharpe & Skakkebaek, 1993; Toppariet al., 1996). Cryptorchidism and hypospadias are the two most common congenital malformations that comprise a testicular dysgenesis syndrome (TDS), which arises during fetal development and manifests in adulthood (Skakkebaek et al., 2001).

Several studies have shown that increased intratesticular temperature in cryptorchid testes affects spermatogenesis, resulting in either reduced fertility or infertility. Other evidences collected over the years have indicated that increased testicular temperature negatively influences the development and differentiation of Leydig cells causing impairments in sex hormones biosynthesis (Huff et al., 2001; Kotula-Balak et al., 2001; Pinart et al., 2000).

Our recent studies have shown that in cryptorchid horses disturbances in differentiation and/or maturation of Leydig cells may be related to altered intracellular communication. In these animals decreased immunoexpression of gap junction protein, connexin 43, in testicular cells were accompanied with reduced expression of LHR, 3β-HSD and disturbed androgen/estrogen balance (Hejmej et al., 2005, 2007; Hejmej & Bilinska, 2008), (Figure 4). Altered expression of these proteins and imbalance in sex hormones level detected in cryptorchid horses suggested their additional influence on morphology and function of undescended testis. Markedly reduced expression of 3β-HSD has been also reported in rats with experimentally induced cryptorchidism (Wisner & Gomes, 1978). No significant changes in T levels have been detected in patients with cryptorchidism as well as other mammalian species (Bilinska et al., 2003; Farrer et al., 1985; Illera et al., 2003; Kawakami et al., 1999; Ren et al., 2006; Ryan et al., 1986).

Figure 4.

Immunohistochemical localization of 3β-HSD in testis of normal (A) and cryptorchid stallion (B). Counterstaining with Mayer’s haematoxylin. The presence of 3β-HSD is confined to Leydig cells (arrows). Note a clearly weaker staining in the cryptorchid horse (A) than in the healthy stallion (B). LC-Leydig cells, ST-seminiferous tubules. Bars 20 µm.

5.2. 3β-HSD and 17β-HSD deficiency

The development of the male internal and external genitalia in an XY fetus requires a complex interplay of many critical genes, enzymes and cofactors. In early fetal life, in the bipotential embryo, both Wolffian ducts and Müllerian ducts are present. Testosterone produced by FLCs acts on AR to stabilize the Wolffian ducts whereas MIS causes regression of Müllerian ducts (George et al., 2010). The formation of male external genitalia is induced by T and DHT.

Disruption in androgen production and/or action leads to disorder of sex development (DSD) also known as male pseudohermaphroditism. DSD is defined as a congenital condition in which development of chromosomal, gonadal or anatomical sex is atypical in such individuals (Hughes et al., 2006). 46, XY DSD is an autosomal recessive form of DSD which was first described in 1971 (Saez et al., 1971). Disturbances of androgen production can occur in all steps of T biosynthesis and its conversion into DHT.

Around 40 various mutations have already been described in HSD3B2gene. Mutation in this gene results in 3β-HSD II deficiency and decreased T biosynthesis (Payne & Hales, 2004). Severe form of 3β-HSD deficiency named congenital adrenal hyperplasia (CAH) impairs also steroidogenesis in adrenals (Moisan et al., 1999). In male patients, either perineal hypospadias or perineoscrotal hypospadias and ambiguous external genitalia or microphallus have been reported (Simard et al., 2005). Also, in these individuals gynecomastia has been observed as common at puberty. Serum levels of Δ5 steroids are elevated whereas levels of Δ4 steroids are slightly increased. In adulthood, males with 3β-HSD II deficiency can reach normal levels of T due to the peripheral conversion of elevated Δ5 steroids by 3β-HSD I and/or due to testicular stimulation by high LH levels. Most of the patients with mutation in HSD3B2gene are raised as males and display male social sex but there are some cases described where such individuals are castrated in childhood and treated as female (Mendonca et al., 2008). Males with 3β-HSD II deficiency share common clinical features with patients deficient for 17β-HSD 3 and 5α-reductase 2.

Deficiency of the 17β-HSD 3 can be caused by either homozygous or compound heterozygous mutations in the HSD17B3gene (Geissler et al., 1994). This autosomal recessive disorder manifests in males as undermasculinization characterized by hypoplastic-to-normal internal genitalia (epididymis, vas deferens, seminal vesicles, and ejaculatory ducts), but female external genitalia and the absence of a prostate (Boehmer et al., 1999; Lindqvist et al., 2001; Sinnecker et al., 1996; Ulloa-Aguirre et al., 1985).

At the time of puberty, there is a marked increase in plasma LH and, consequently, in testicular secretion of androstenedione. Mendonca et al. (2010) have found that significant amounts of the circulating androstenedione are converted to T in peripheral tissues by an unidentified member of the 17β-HSD family, thereby causing virilization in many of these individuals. To date, 19 mutations in the HSD17B3gene have been found. Most of these patients are raised as girls during childhood but starts to display masculine behavior at puberty (Mendonca et al., 2008).

Advertisement

6. Conclusion

In Leydig cells, multiple factors regulate 3β-HSD and 17β-HSD function exerting very diverse effect. Nowadays further characterization of physiological and pathological conditions as well as endogenous and exogenous agents that can modify HSDs expression is becoming increasingly necessary. Especially, in light of recent reports indicating an increase in the incidences of developmental and functional disorders of the male reproductive tract. Exploration of the site and possible mechanisms of action of these agents in steroid biosynthesis is becoming important future research direction.

Acknowledgement

This work was financially supported by the Ministry of Science and Higher Education, Grant N N303816640.

References

  1. 1. AkingbemiB. T.GeR.RosenfeldC. S.NewtonL. G.HardyD. O.CatterallJ. F.LubahnD. B.KorachK. S.HardyM. P.2003Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology,1441(January 2003),8493,1477-7827
  2. 2. AlmeidaJ.ConleyA. J.MathewsonL.BallB. A.2011Expression of steroidogenic enzymes during equine testicular development. Reproduction,1416(June 2011),841878,1470-1626
  3. 3. AndersrsonS.GeisslerW. M.PatelS.LingW.1995The molecular biology of androgenic 17β-hydroxysteroid dehydrogenases. Journal of Steroid Biochemistry and Molecular Biology,531-6, (June, 1995),3739,0960-0760
  4. 4. AriyaratneH. B. S.Mendis-HandagamaS. M. L. C.2000Structural and functional changes in the testis interstitium of Sprague Dawley rats from birth to adulthood. Biology of Reproduction,623(March 2000),680690,1470-1626
  5. 5. BadrinarayananS.RengarajanP.NithyaP.BalasubramanianK.2006Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells. Biochemistry and Cell Biology,845(October 2006),745754,0829-8211
  6. 6. BakerP. J.ShaJ. A.Mc BrideM. W.PengL.PayneA. H.O’ShaughnessyP. J.1999Expression of 3β-hydroxysteroid dehydrogenase type I and type VI isoforms in the mouse testis during development. European Journal of Biochemistry,2603(March 1999),911917,0014-2956
  7. 7. BartkeA.StegerR. W.1992Seasonal changes in the function of the hypothalamic-pituitary-testicular axis in the Syrian hamster. Proceedings of the Society for Experimental Biology and Medicine,1992(February 1992),139148,0037-9727
  8. 8. BentonL.ShanL. X.HardyM. P.1995Differentiation of adult Leydig cells. Journal of Steroid Biochemistry and Molecular Biology,531-6, (June 1995),6168,0960-0760
  9. 9. BilinskaB.1979Histochemical demonstration of 5, 3β-hydroxysteroid dehydrogenase activity in cultured Leydig cells under the influence of gonadotropic hormones and testosterone. International Journal of Andrology,21-6, (December 1979),385394, ISNN 0105-6263
  10. 10. BilinskaB.1983Effect of in vitro administration of LH, prolactin separately and LH and prolactin in mixture, on cultured Leydig cells from mouse testes: Changes of 5, 3β-hydroxysteroid dehydrogenase during postnatal life. Folia Histochemica et Cytochemica,211(1983),2332,0015-5586
  11. 11. BilinskaB.1994Staining with ANS fluorescent dye reveals distribution of mitochondria and lipid droplets in cultured Leydig cells. Folia Histochemica et Cytobiologica,321(1994),2124,0239-8508
  12. 12. BilinskaB.DragE.Schmalz-FraczekB.1999Immunolocalization of androgen receptors intesticular cells during postnatal development of the bank vole (Clethrionomys glareolus, S). Tissue & Cell,316(December 1999),621626,0040-8166
  13. 13. BilinskaB.Kotula-BalakM.GancarczykM.SadowskaJ.TaborowskiZ.WojtusiakA.2003Androgen aromatization in cryptorchid mouse testis. Acta Histochemica,1051(2003),157165,0065-1281
  14. 14. BilinskaB.Schmalz-FraczekB.KotulaM.CarreauS.2001Photoperiod-dependent capability of androgen aromatization and the role of estrogens in the bank vole testis visualized by means of immunohistochemistry. Molecular and Cellular Endocrinology,10178(June 2001),189198,0303-7207
  15. 15. BilinskaB.Schmalz-FraczekB.SadowskaJ.CarreauS.2000Localization of cytochrome P450aromatase and estrogen receptors alpha and beta in testicular cells- an immunohistochemical study of the bank vole. Acta Histochemica,1022(May 2000),167181,0065-1281
  16. 16. Blanchard-GP.Luu-TheV.2007Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17β-hydroxysteroid dehydrogenase. Journal of Endocrinology,1942(August 2007),449455,0022-0795
  17. 17. BoehmerA. L.BrinkmannA. O.SandkuijlL. A.HalleyD. J.NiermeijerM. F.AnderssonS.de JongF. H.KayseriliH.de VroedeM. A.OttenB. J.RouweC. W.MendoncaB. B.RodriguesC.BodeH. H.de RuiterP. E.Delemarre-van deWaal. H. A.DropS. L.199917beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. Journal of Clinical Endocrinology & Metabolism,8412(December 1999),47134721,0002-1972X
  18. 18. CarreauS.LambardS.DelalandeC.Denis-GaleraudI.BilinskaB.BourguibaS.2003Aromatase expression and role of estrogens in male gonad: a review. Reproductive Biology and Endocrinology,111(April 2003),351477-7827
  19. 19. ChenH.CangelloD.BensonS.FolmerJ.ZhuH.TrushM. A.ZirkinB. R.2001Age-related increase in mitochondrial superoxide generation in the testosterone-producing cells of Brown Norway rat testes: relationship to reduced steroidogenic function? Experimental Gerontology,368(August 2001),13611373,0531-5565
  20. 20. ChenH.GeR. S.ZirkinB. R.2009Leydig cells: From stem cells to aging. Molecular and Cellular Endocrinology,10306Issue 1-2, (July 2009),916,0303-7207
  21. 21. ChenH.HardyM. P.ZirkinB. R.2002Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro. Endocrinology,1435(May 2002),16371642,1477-7827
  22. 22. ChenH.StanleyE.JinS.ZirkinB. R.2010Stem Leydig cells: from fetal to aged animals. Birth Defects Research Part C Embryo Today,904(December 2010),272283,0154-2975X
  23. 23. CherradiN.ChambazE. M.DefayeG.1995Organization of 3β-hydroxysteroid dehydrogenase/isomerase and cytochrome P450scc into a catalytically active molecular complex in bovine adrenocortical mitochondria. Journal of Steroid Biochemistry and Molecular Biology,555-6, (December 1995),507514,0960-0760
  24. 24. DombrowiczD.SenteB.ClossetJ.HennenG.1992Dose-dependent effects of human prolactin on the immature hypophysectomized rat testis. Endocrinology,1302(February 1992),695700,0013-7227
  25. 25. DongL.JelinskyS. A.FingerJ. N.JohnstonD. S.KopeG. S.SottasC. M.HardyM. P.Ge-SR.2007Gene expression during development of fetal and adult Leydig cells. Annals of the New York Academy of Science,1120(December 2007),1635,0077-8923
  26. 26. EddyE. M.WashburnT. F.BunchD. O.GouldingE. H.GladenB. C.LubahnD. B.KorachK. S.1996Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology,13711(November 1996),47964805,1477-7827
  27. 27. El -HefnawyT.MannaP. R.LuconiM.BaldiE.SlotteJ. P.HuhtaniemiI.2000Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type. Endocrinology,1411(January 2000),247255,0013-7227
  28. 28. El -HefnawyT.HuhtaniemiI.1998Progesterone can participate in down-regulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells. Molecular and Cellular Endocrinology,1372(February 1998),127138,0303-7207
  29. 29. FarrerJ. H.SikkaS. C.XieH. W.ConstantinideD.RajferJ.1985Impaired testosterone biosynthesis in cryptorchidism. Fertility and Sterility,441(July 1985),125132,0015-0282
  30. 30. FluckC. E.MillerW. L.AuchusR. J.2003The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway. Journal of Clinical Endocrinology & Metabolism,888(August 2003),37623766,0002-1972X
  31. 31. FreemanD. A.1985Estradiol acts as a competitive inhibitor of the 3beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase enzyme of cultured Leydig tumor cells. Endocrinology,1175(November 1985),21272133,0013-7227
  32. 32. FrungieriM. B.Gonzales-CalvarsiCl.BartkeA.CalendaraR. S.1999Influence of age and photoperiod on steroidogenic function of the testis in the golden hamster. International Journal of Andrology,224(August 1999),243252,0105-6263
  33. 33. FrungieriM. B.MayerhoferA.ZittaK.PignataroO. P.CalandraR. S.Gonzales-CalvarS. I.2005Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system. Endocrinology,1463(March 2005),15411552,1477-7827
  34. 34. GancarczykM.TworzydloW.SzlachtaA.SadowskaJ.BilinskaB.2003Hormonal regulation of estrogen formation by Leydig cells in vitro: immunocytochemical approach. Folia Biologica (Krakow),513-4, (2003),181188,0015-5497
  35. 35. GancarczykM.KuklinskaM.SadowskaJ.StrzezekJ.BilinskaB.2006Aromatization and antioxidant capacity in the testis of seasonally breeding bank voles: Effects of LH, PRL and IGF-I. Theriogeneology,1565Issue 7 (April 2006),13761391,0009-3691X
  36. 36. GancarczykM.Paziewska-HejmejA.CarreauS.TabarowskiZ.BilinskaB.2004Dose- and photoperiod-dependent effects of 17beta-estradiol and the anti-estrogen ICI 182, 780 on testicular structure, acceleration of spermatogenesis, and aromatase immunoexpression in immature bank voles. Acta Histochemica,1064(2004),269278,0065-1281
  37. 37. GeR. S.HardyM. P.1997Decreased cyclin A2 and increased cyclin G1 levels coincide with loss of proliferative capacity in rat Leydig cells during pubertal development. Endocrinology,1389(September 1998),37193726,1477-7827
  38. 38. GeisslerW. M.DavisD. L.WuL.BradshawK. D.PatelS.MendoncaB. B.EllistonK. O.WilsonJ. D.RussellD. W.AnderssonS.1994Male pseudohermaphroditism caused by mutations of testicular 17beta-hydroxysteroid dehydrogenase 3. Nature Genetics,71(May 1994),3439,1061-4036
  39. 39. GeorgeM. M.NewM. I.TenS.SultanC.BhangooA.2010The clinical and molecular heterogeneity of 17β-HSD-3 enzyme deficiency. Hormone Research in Paediatrics,744(2010),229240,1663-2818
  40. 40. HabertR.PiconR.1984Testosterone, dihydrotestosterone and estradiol-17beta levels in maternal and fetal plasma and in fetal testes in the rat. Journal Steroid Biochemistry,212(August 1984),193198,0022-4731
  41. 41. HaiderS. G.2004Cell biology of Leydig cells in the testis. International Review of Cytology,233(2004),181241,0007-4769
  42. 42. HanceM. W.MasonJ. I.Mendis-HandagamaS. M.2009Effects of photo stimulation and nonstimulation of golden hamsters (Mesocricetus auratus) from birth to early puberty on testes structure and function. Histology and Histopathology,2411(November 2009),14171424,0213-3911
  43. 43. HardyM. P.ZirkinB. R.EwingL. L.1989Kinetic studies on the development of the adult population of Leydig cells in testes of prepubertal rat. Endocrinology,1242(February 1989),762770,1477-7827
  44. 44. HardyM. P.KelceW. R.KlinefelterG. R.EwingL. L.1990Differentiation of Leydig cell precursors in vitro: a role for androgen. Endocrinology,1271(July 1990),488490,1477-7827
  45. 45. HarmanS. M.MetterE. J.TobinJ. D.PearsonJ.BlackmanM. R.BaltimoreLongitudinal.Studyof.AgingLongitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.2001Journal of Clinical Endocrinology & Metabolism,862(February 2001),724731,0002-1972X
  46. 46. HayakawaD.SasakiM.SuzukiM.TsubotaT.IgotaH.KajakiK.KitamuraN.2010Immunohistochemical localization of steroidogenic enzymes in the testis of the sika deer (Cervus nippon) during developmental and seasonal changes. Journal of Reproduction and Development,561(February 2010),117123,0916-8818
  47. 47. HejmejA.BilinskaB.2008The effects of cryptorchidism on the regulation of steroidogenesis and gap junctional communication in equine testes. Polish Journal of Endocrinology,592(March-April 2008),112118,0042-3104X
  48. 48. HejmejA.GorazdM.Kosiniak-KamyszK.WiszniewskaB.SadowskaJ.BilinskaB.2005Expression of aromatase and oestrogen receptors in reproductive tissues of the stallion and a single cryptorchid visualised by means of immunohistochemistry. Domestic Animal Endocrinology,293(October 2005),534547,0739-7240
  49. 49. HejmejA.Kotula-BalakM.BilinskaB.2011aAntiandrogenic and estrogenic compounds: Effect on development and function of male reproductive system. In: Steroids, Abduljabbar, H. (ed.),5381, InTech,978-9-53307-705-5Rijeka, Croatia.
  50. 50. HejmejA.Kotula-BalakM.GalasJ.BilinskaB.2011bEffects of 4-tert-octylphenol on the testes and seminal vesicles in adult male bank voles. Reproductive Toxicology,311(January 2011),95105,0890-6238
  51. 51. HejmejA.Kotula-BalakM.SadowskaJ.BilinskaB.2007Expression of connexin 43 protein in testes, epididymides and prostates of stallions. Equine Veterinary Journal,392(March 2007),122127,0425-1644
  52. 52. HerrmannM.SchölmerichJ.StraubR. H.2002Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro. A short tabular data collection. Annals of New York Academy of Sciences,966(June 2002),166186,0077-8923
  53. 53. HuG. X.ZhaoB. H.ChuY. H.ZhouH. Y.AkingbemiB. T.ZhengZ. Q.GeR. S.Effects of genistein and equol on human and rat testicular 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities. Asian Journal of Andrology,12124(July 2010),519526,0100-8682X
  54. 54. HuffD. S.FenigD. M.CanningD. A.CarrM. G.ZdericS. A.SnyderH.33rd. (2001) Abnormal germ cell development in cryptorchidism. Hormone Research,551(2001),1117,0301-0163
  55. 55. Hughes, I.A.; Houk, C.; Ahmed, S.F. & Lee, P.A.; & Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group2006Consensus statement on management of intersex disorders. Journal of Pediatric Urology,23(June 2006),148162,1477-5131
  56. 56. HuhtaniemiI. T.NozuK.WarrenD. W.DufauM. L.CattK. J.1982Acquisition of regulatory mechanisms for gonadotropin receptors and steroidogenesis in the maturing rat testis. Endocrinology,1115(November 1982),17111720,1477-7827
  57. 57. HuhtaniemiI.PelliniemiL. J.1992Fetal Leydig cells: Cellular origin, morphology, life span, and special functional features. Proceedings of the Society for Experimental Biology and Medicine,2012(November 1992),125140,0037-9727
  58. 58. HutsonJ. C.1989Leydig cells do not have Fc receptors. Journal of Andrology,102(March-April 1989),159165,0000-0196- 3635
  59. 59. IlleraJ. C.SilvanG.MunroC. J.LorenzoP. L.IlleraM. J.LiuI. K.IlleraM.2003Amplified androstenedione enzyme immunoassay for the diagnosis of cryptorchidism in the male horse: comparison with testosterone and estrone sulphate methods. Journal of Steroid Biochemistry and Molecular Biology,842-3, (February 2003),377382,0960-0760
  60. 60. IvellR.BalversM.AnandR. J. K.Paust-JH.MckinnellC.SharpeR.2003Differentiation-dependent expression of 17β-hydroxysteroid dehydrogenase, type 10, in the rodent testis: Effect of aging in Leydig cells. Endocrinology,1447(July 2003),31303137,1477-7827
  61. 61. IvellR.Kotula-BalakM.GlynnD.HengK.Anand-IvellR.2011Relaxin family peptides in the male reproductive system a critical appraisal. Molecular and Human Reproduction,172(February 2011),7184,1360-9947
  62. 62. KawakamiE.HoriT.TsutsuiT.1999Function of contralateral testis after artificial unilateral cryptorchidism in dogs. Journal of Veterinary Medical Science,6110(1999),11071111,0916-7250
  63. 63. KeeneyD. S.MasonJ. I.1992Expression of testicular 3β-hydroxysteroid dehydrogenase/5-4-isomerase: regulation by luteinizing hormone and forskolin in Leydig cells of adult rats. Endocrinology,1304(April 1992),20072015,0013-7227
  64. 64. KimS. K.KimJ. H.HanJ. H.YoonY. D.2008Inhibitory effect of tributyltin on expression of steroidogenic enzymes in mouse testis. International Journal of Toxicology,272(March-April 2008),175182,1091-5818
  65. 65. KmicikiewiczI.BilinskaB.1997The effect of IL-1 on basal and hCG-stimulated testosterone secretion by Leydig cells of the bank voles (Clethrionomys glareolus, S.). Folia Histochemica et Cytobiologica,352(1997),9596,0239-8508
  66. 66. KmicikiewiczI.WojtusiakA.BilinskaB.1999The effect of testicular macrophages, macrophage-conditioned medium and interleukin-1alpha on bank vole Leydig cell steroidogenesis. Experimental and Clinical Endocrinology & Diabetes,1074(1999)262271,0947-7349
  67. 67. KoperaI.TuzR.Kotula-BalakM.SchwarzT.KoczanowskiJ.BilinskaB.2008Morphofunctional alterations in testicular cells of deslorelin-treated boars: an immunohistochemical study. Journal of Experimental Zoology,1309Issue 3, (March 2008),117126,1932-5223
  68. 68. KosticT. S.StojkovN. J.BjelicM. M.MihajlovicA. I.JanjicM. M.AndricS. A.2011Pharmacological doses of testosterone upregulated androgen receptor and 3-beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase and impaired Leydig cells steroidogenesis in adult rats. Toxicological Sciences,1212(June 2011),397407,1096-6080
  69. 69. Kotula-BalakM.PochecE.HejmejA.DudaM.BilinskaB.2011Octylphenol affects morphology and steroidogenesis in mouse tumor Leydig cells. Toxicology In Vitro,255(August 2011),10181026,0887-2333
  70. 70. Kotula-BalakM.SlomczynskaM.FraczekB.BourguibaS.TabarowskiZ.CarreauS.BilinskaB.2003Complementary approaches demonstrate that cellular aromatization in the bank vole testis is related to photoperiod. European Journal Histochemistry,471(2003),5562,0112-1760X
  71. 71. Kotula-BalakM.WojciechowskaJ.BilinskaB.2001The site of aromatization in the mouse cryptorchid testis. Folia Biologica (Krakow),493-4, (2001),279283,0015-5497
  72. 72. KumarV.ChakrabortyA.KuralM. R.RoyP.2009Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reproductive Toxicology,272(April 2009),177185,0890-6238
  73. 73. LinY. M.LiuM. Y.PoonS. L.LeuS. F.HuangB. M.2008Gonadotrophin-releasing hormone-I and- II stimulate steroidogenesis in prepubertal murine Leydig cells in vitro. Asian Journal of Andrology,106(November 2008),929936,0100-8682X
  74. 74. LindqvistA.HughesI. A.AnderssonS.2001Substitution mutation C268Y causes 17β-hydroxysteroid dehydrogenase 3 deficiency. Journal of Clinical Endocrinology & Metabolism,862February 2001),921923,0002-1972X
  75. 75. LiuH.ZhengS.BellemareV.PelletierG.LabrieF.Luu-TheV.2007Expression and localization of estrogenic type 12 17β-hydroxysteroid dehydrogenase in the cynomolgus monkey. BMC Biochemistry,58(February 2007),21471-2091
  76. 76. LuoL.ChenH.ZirkinB. R.1996Are Leydig cell steroidogenic enzymes differentially regulated with aging? Journal of Andrology,175(September-October 1996),509515,0000-0196- 3635
  77. 77. MannaP. R.El -HefnawyT.KeroJ.HuhtaniemiI. T.2001Biphasic action of prolactin in the regulation of murine Leydig tumor cell functions. Endocrinology,1421(January 2001),308318,1477-7827
  78. 78. MaranR. R.2003Thyroid hormones: their role in testicular steroidogenesis. Archives of Andrology,495(September-October 2003),375388,0000-0148- 5016
  79. 79. MathieuA. P.AuchusR. J.Le HouxJ. G.2002Comparison of the hamster and human adrenal P450c17 (17alpha-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling. Journal of Steroid Biochemistry and Molecular Biology,801(January 2002),99107,0960-0760
  80. 80. MatsumotoA. M.2002Andropause: clinical implications of the decline in serum testosterone levels with aging in men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences,572(February 2002),M76M99,1079-5006
  81. 81. Mc KeeverB. M.HawkinsB. K.GeisslerW. M.WuL.SheridanR. P.MosleyR. T.AnderssonS.2002Amino acid substitution of arginine 80 in 17β-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics. Biochimica et Biophysica Acta,16011(January 2002),2937,0006-3002
  82. 82. Mc VeyM. J.CookeG. M.2003Inhibition of rat testis microsomal 3beta-hydroxysteroid dehydrogenase activity by tributyltin. Journal of Steroid Biochemistry and Molecular Biology,861(July 2003),99105,0960-0760
  83. 83. Mendis-HandagamaS. M.AriyaratneH. B.2001Differentiation of the adult Leydig cell population in the postnatal testis. Biology of Reproduction,653(September 2001),660671,1470-1626
  84. 84. Mendis-HandagamaS. M.AriyaratneH. B.Teunissen vanManen. K. R.HauptR. L.1998Differentiation of adult Leydig cells in the neonatal rat testis is arrested by hypothyroidism. Biology of Reproduction,592(August 1998),351357,1470-1626
  85. 85. MendoncaB. B.CostaE. M. F.BelgoroskyA.RivarolaM. A.DomeniceS.201046,XY DSD due to impaired androgen production. Best Practice & Research Clinical Endocrinology & Metabolism,242(April 2010),243262,0152-1690X
  86. 86. MendoncaB. B.DomeniceS.ArnholdI. J. P.CostaE. M. F.200846,XY disorders of sexual development. In: Pediatric Endocrinology, New, M. (ed.), endotex.com,http://www.endotext.org/pediatrics/pediatrics11/pediatricsframe11.htm
  87. 87. MidzakA. S.ChenH.PapadopoulosV.ZirkinB. R.2009Leydig cell aging and the mechanisms of reduced testosterone synthesis. Molecular and Cellular Endocrinology,5299Issue 1, (February 2009),2331,0303-7207
  88. 88. MoisanA. M.RickettsM. L.TardyV. R.DesrochersM.BarkiF. M.(1999) New insight into the molecular basis of 3β-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. Journal of Clinical Endocrinology & Metabolism, Vol. 84, No. 12 (December 1999), pp. 4410-4425, ISSN 1521-690X
  89. 89. OettelM.MukhopadhyayA. K.2004Progesterone: the forgotten hormone in men? Aging Male,73(September 2004),236257,1368-5538
  90. 90. OhnoS.NakajimaY.NakajinS.2005Triphenyltin and tributyltin inhibit pig testicular 17beta-hydroxysteroid dehydrogenase activity and suppress testicular testosterone biosynthesis. Steroids,709(August 2005),645651,0000-0585- 2617
  91. 91. OhsakoS.KubotaK.KurosawaS.TakedaK.QingW.IshimuraR.TohyamaC.2003Alterations of gene expression in adult male rat testis and pituitary shortly after subacute administration of the antiandrogen flutamide. Journal of Reproduction and Development,494(August 2003),275290,0916-8818
  92. 92. O’ShaughnessyP. J.BakerP. J.HeikkiläM.VainioS.Mc MahonA. P.2000Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis-androstenedione is the major androgen secreted by fetal/neonatal Leydig cells. Endocrinology,1417(July 2000),26312637,0013-7227
  93. 93. O’ShaughnessyP. J.BakerP.SohniusU.HaavistoA. M.CharltonH. M.HuhtaniemiI.1998Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function. Endocrinology,1393(March 1993),11411146,0477-7827
  94. 94. O’ShaughnessyP. J.JohnstonH.WillertonL.BakerP. J.2002bFailure of normal adult Leydig cell development in androgen-receptor-deficient mice. Journal of Cell Science,1115Issue Pt17, (September 2002),34913496,0021-9533
  95. 95. O’ShaughnessyP. J.MonteiroA.VerhoevenG.De GendtK.AbelM. H.2010Effect of FSH on testicular morphology and spermatogenesis in gonadotrophin-deficient hypogonadal mice lacking androgen receptors. Reproduction,1391(January 2010),177184,1470-1626
  96. 96. O’ShaughnessyP. J.MorrisI. D.HuhtaniemiI.BakerP. J.AbelM. H.2009Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice. Molecular and Cellular Endocrinology,10306Issue 1-2, (July 2009),28,0303-7207
  97. 97. ParvinenM.1982Regulation of the seminiferous epithelium. Endocrine Reviews,34(1982),404417,0016-3769X
  98. 98. PayneA. H.2007Steroidogenic enzymes in Leydig cells. In: The Leydig cell in health and disease. Payne, A.H. & Hardy, M.P. (eds.),157171, Humana Press Inc.,978-1-58829-754-9Totowa, NJ
  99. 99. PayneA. H.HalesD. B.2004Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Reviews,256(December 2004),947970,0016-3769X
  100. 100. PayneA. H.ShaL. L.1991Multiple mechanisms for regulation of 3β-hydroxysteroid dehydrogenase/5-4-isomerase,17β-hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. Endocrinology,1293(September 1991),14291435,0013-7227
  101. 101. PelletierG.2000Localization of androgen and estrogen receptors in rat and primate tissues. Histology and Histopathology,154(October 2000),12611270,0213-3911
  102. 102. PelletierG.LiS.Luu-TheV.TremblayY.BelangerA.LabrieF.2001Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3β-hydroxysteroid dehydrogenase and cytochrome P450((c17)) in rat adrenal cortex and gonads. Journal of Endocrinology,1712(November 2000),373383,0022-0795
  103. 103. PinartE.SanchoS.BrizM. D.BonetS.GarciaN.BadiaE.2000Ultrastructural study of the boar seminiferous epithelium: changes in cryptorchidism. Journal of Morphology,2443(June 2000),190202,0062-2525
  104. 104. PintoM. E.EgydioFde. M.TabogaS. R.Mendis-HandagamaS. M.GóesR. M.2010Differentiation of Leydig cells in the Mongolian gerbil. Microscope Research and Techniques,732(February 2010),119127,0105-9910X
  105. 105. Pogrmic-MajkicK.FaS.DakicV.KaisarevicS.KovacevicR.2010Upregulation of peripubertal rat Leydig cell steroidogenesis following 24 h in vitro and in vivo exposure to atrazine. Toxicological Sciences,1181(November 2010),5260,1096-6080
  106. 106. PushpalathaT.ReddyP. R.ReddyP. S.2003Effect of prenatal exposure to hydroxyprogesteroneon steroidogenic enzymes in male rats. Naturwissenschaften,901(January 2003),4043,0028-1042
  107. 107. RaoM. V.ChinoyN. J.1986Effect of estradiol benzoate on rat testis and adrenal. Experimental and Clinical Endocrinology,882(December 1986),181184,0232-7384
  108. 108. RenL.MedanM. S.OzuM.LiC.WatanabeG.TayaK.2006Effects of experimental cryptorchidism on sperm motility and testicular endocrinology in adult male rats. Journal of Reproduction and Development,522(April 2006),219228,0916-8818
  109. 109. Ruiz deGalarreta. C. M.FanjulL. F.MeidanR.HsuehA. J.1983Regulation of 3β-hydroxysteroid dehydrogenase activity by human chorionic gonadotropin, androgens, and anti-androgens in cultured testicular cells. Journal of Biological Chemistry,25258Issue 11, (September 1983),1098810996,0021-9258
  110. 110. RyanP. L.FriendshipR. M.RaesideJ. I.1986Impaired estrogen production by Leydig cells of the naturally retained testis in unilaterally cryptorchid boars and stallions. Journal of Andrology,72(March-April 1986),100104,0105-6263
  111. 111. SaezJ. M.De PerettiE.MoreraA. M.DavidM.BertrandJ.1971Familial male pseudohermaphroditism with gynecomastia due to a testicular17-ketosteroid reductase defect. I. Studies in vivo. Journal of Clinical Endocrinology & Metabolism,325(May 1971),604610,0152-1690X
  112. 112. SchäfersB. A.SchlutiusB. G.HaiderS. G.2001Ontogenesis of oxidative reaction of 17β-hydroxysteroid dehydrogenase and 11β-hydroxysteroid dehydrogenase in rat Leydig cells, a histochemical study. Histochemical Journal,339-10, (September-October 2001),585595,0018-2214
  113. 113. SchwarzenbachH.MannaP. R.StoccoD. M.ChakrabartiG.MukhopadhyayA. K.2003Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells. Biology of Reproduction,683(March 2003),10541063,1470-1626
  114. 114. ScottH. M.MasonJ. I.SharpeR. M.2009Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocrine Reviews,307(December 2009),883925,0016-3769X
  115. 115. ShanL. X.PhillipsD. M.BardinC. W.HardyM. P.1993Differential regulation of steroidogenic enzymes during differentiation optimizes testosterone production by adult rat Leydig cells. Endocrinology,1335(November 1993),22772283,1477-7827
  116. 116. SharpeR. M.SkakkebaekN. E.1993Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet,29341(May 1993),13921395,0140-6736
  117. 117. SierensJ. E.SneddonS. F.CollinsF.MillarM. R.SaundersP. T.2005Estrogens in testis biology. Annals of the New York Academy of Sciences,1061(December 2005),6576,0077-8923
  118. 118. SimardJ.Ricketts-LM.GingrasS.SoucyP. F.FeltusF. A.MelnerM. H.2005Molecular biology of the 3β-hydroxysteroid dehydrogenase/5-4 isomerase gene family. Endocrine Reviews,264(June 2005),525582,0016-3769X
  119. 119. SinneckerG. H.HiortO.DibbeltL.AlbersN.DorrH. G.HaussH.HeinrichU.HemminghausM.HoepffnerW.HolderM.SchnabelD.KruseK.1996Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. American Journal of Medical Genetics,363Issue 1, (May 1996),223230,0148-7299
  120. 120. SkakkebaekN. E.Rajpert DeMeyts. E.MainK.2001Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction,165(May 2001),972978,0268-1161
  121. 121. SordoilletC.SavonaC.ChauvinM. A.de PerettiE.FeigeJ. J.MoreraA. M.BenahmedM.1992Basic fibroblast growth factor enhances testosterone secretion in cultured porcine Leydig cells: site(s) of action. Molecular and Cellular Endocrinology,891-2, (November 1992),163171,0303-7207
  122. 122. TähkäK. M.TähkäK. M.TeräväinenT.WallgrenH.1982Effect of photoperiod on the testicular steroidogenesis of the bank vole (Clethrionomys glareolus, Schreber): an in vitro study. General and Comparative Endocrinology,473(July 1982),377384,0016-6480
  123. 123. TapanainenJ.KuopioT.PelliniemiL. J.HuhtaniemiI.1984Rat testicular endogenous steroids and number of Leydig cells between the fetal period and sexual maturity. Biology of Reproduction,315(December 1984),10271035,1470-1626
  124. 124. TeerdsK. J.RijntjesE.2007Dynamics of Leydig cell regeneration after EDS: A model for postnatal Leydig cell development. In: The Leydig cell in health and disease. Payne, A.H. & Hardy, M.P. (eds.),91116, Humana Press Inc.,978-1-58829-754-9Totowa, NJ
  125. 125. Teerds, K.J.; Rijntjes, E.; Veldhuizen-Tsoerkan, M.B.; Rommerts, F.F. & de Boer-Brouwer M. (2007) The development of rat Leydig cell progenitors in vitro: how essential is luteinising hormone? Journal of Endocrinology, Vol. 194, No. 3, (September 2007), pp. 579-593, ISSN 0022-0795
  126. 126. Teerds, K.J.; de Rooij, D.G.; de Jong, F.H. & van Haaster, L.H. (1998) Development of the adult-type Leydig cell population in the rat is affected by neonatal thyroid hormone levels. Biology of Reproduction, Vol. 59, No. 2, (August 1998), pp. 344-350, ISSN 1470-1626
  127. 127. Toppari, J.; Larsen, J.C.; Christiansen, P.; Giwercman, A.; Grandjean, P.; Guillette, Jr.L.J.; Jegou, B.; Jensen, T.K.; Jouannet, P.; Keiding, N.; Leffers, H.; McLachlan, J.A.; Meyer, O.; Muller, J.; Rajpert-De Meyts, E.; Scheike, T.; Sharpe, R.; Sumpter, J. & Skakkebaek, N.E. (1996) Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives, Vol. 104, Suppl. 4, (August 1996), pp. 741-803, ISSN 0091-6765
  128. 128. Tsubota, T.; Howell-Skalla, L.; Nitta, H.; Osawa, Y.; Mason, J.I.; Meiers, P.G.; Nelson, R.A. & Bahr, J.M. (1997) Seasonal changes in spermatogenesis and testicular steroidogenesis in the male black bear Ursus americanus. Journal of Reproduction and Fertility, Vol. 109, No. 1, (January 1997), pp. 21-27, ISSN 0022-4251
  129. 129. Tsubota, T.; Nagashima, T.; Kohyama, K.; Maejima, K.; Murase, T. & Kita, I. (2001) Seasonal changes in testicular steroidogenesis and spermatogenesis in a northern fur seal, Callorhinus ursinus. Journal of Reproduction and Development, Vol. 47, No. 6, (December 2001), pp. 415-420, ISSN 0916-8818
  130. 130. Ulloa-Aguirre, A.; Bassol, S.; Poo, J.; Mendez, J.P.; Mutchinick, O.; Robles, C. & Perez-Palacios, G. (1985) Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency. Journal of Clinical Endocrinology & Metabolism, Vol. 60, No. 4, (April 1985), pp. 639-643, ISSN 1521-690X
  131. 131. Vaithinathan, S.; Saradha, B. & Mathur, P.P. (2008) Transient inhibitory effect of methoxychlor on testicular steroidogenesis in rat: an in vivo study. Archives in Toxicology, Vol. 82, No. 11, (April 2008), pp. 833-839, ISSN 0340-5761
  132. 132. Verhoeven, G.; Willems, A.; Denolet, E.; Swinnen, J.V, & De Gendt, K. (2010) Androgens and spermatogenesis: lessons from transgenic mouse models. Philosophical Transactions of the Royal Society Series B, Biological Sciences, Vol. 27, No. 1546, (May 2010), pp. 1537-1556, ISSN 1471-2970
  133. 133. Victor-Costa, A.B.; Carozzi Bandeira, S.M.; Oliveira, A.G.; Bohórquez Mahecha, G.A. & Oliveira, C.A. (2010) Changes in testicular morphology and steroidogenesis in adult rats exposed to atrazine. Reproductive Toxicology, Vol. 29, No. 3, (June 2010), pp. 323-331, ISSN 0890-6238
  134. 134. Wang, R-S.; Yeh, S.; Tzeng, C-R. & Chang, C. (2009) Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocrine Reviews, Vol. 30, No. 2, (April 2009), pp. 119-132, ISSN 0163-769X
  135. 135. Wisner, J.R Jr. & Gomes, W.R. (1978) Influence of experimental cryptorchidism on cholesterol side-chain cleavage enzyme and delta5-3beta-hydroxysteroid dehydrogenase activities in rat testes. Steroids, Vol. 31, No. 2, (February 1978), pp. 189-203, ISSN 0585-2617
  136. 136. Wu, X.; Wan, S. & Lee M.M. (2007) Key factors in the regulation of fetal and postnatal Leydig cell development. Journal of Cellular Physiology, Vol. 213, No. 2, (November 2007), pp. 429-433, ISSN 0021-9541
  137. 137. Ye, L.; Zhao, B.; Hu, G.; Chu, Y. & Ge, R-S. (2011) Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A. Toxicology Letters, Vol. 30, No. 207, Issue 2 (November 2011), pp. 137- 142, ISSN 0378-4274
  138. 138. Zirkin, B.R. (2010) Where do adult Leydig cells come from? Biology of Reproduction, Vol. 82, No. 6, (June 2010), pp. 1019-1020, ISSN 1470-1626
  139. 139. Zirkin, B.R. & Chen, H. (2000) Regulation of Leydig cell steroidogenic function during aging. Biology of Reproduction, Vol. 63, No. 4, (October 2000), pp. 977-981, ISSN 0006-3363

Written By

Małgorzata Kotula-Balak, Anna Hejmej and Barbara Bilińska

Submitted: November 22nd, 2011 Published: November 14th, 2012